(Q53718715)
Statements
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. (English)
Axel Le Cesne
Isabelle Ray-Coquard
Florence Duffaud
Emmanuelle Bompas
Didier Cupissol
Jérome Fayette
Antoine Adenis
Sylvie Chabaud
Cecile Guillemet
Catherine Delbaldo
Patrice Berthaud
David Perol
Binh Bui
Patrice Viens
Maria Rios
Pierre Kerbrat
1 March 2007
25
9
1107-1113